Clinical Nuclear Medicine

This work has true international scope, being a unique European/American joint venture that focuses on the state of the art in both diagnostic and therapeutic radionuclide methodology. Pertinent clinical applications are emphasized rather than attempting to cover everything included in the several large comprehensive texts available in our field. This "practical" approach should make it an essential guide to nuclear medicine physicians, technologists, students and interested clinicians alike.

This book serves as a casebook for clinical nuclear medicine neuroimaging. Clinical interpretation of nuclear medicine neuroimaging studies is often challenging, mainly due to the complexity of neuroanatomy and a lack of supportive reference books. This is an unmet need in many teaching hospitals. Utilizing a hands-on, case-based approach, this textbook guides readers through clinical nuclear medicine neuroimaging of major neurological diseases and conditions, including dementia, epilepsy, and brain death. Included here are basic guidelines and techniques for nuclear medicine neuroimaging practices, set alongside case examples that include standardized imaging display and detailed interpretation. Each chapter begins with examples of normal brain imaging as a reference point for the remainder of the chapter, which then presents detailed case examples of these diseases through various imaging techniques. Each of the cases highlights clinical and imaging key findings and precise impressions. This is an ideal guide for residents, fellows, and even practicing nuclear medicine physicians as a reference and teaching tool for neuroimaging in clinical nuclear medicine. It will be of significant value to residents, trainees, and young physicians in preparation for their in-service tests and board examinations.

This book gathers a collection of cases with challenging diagnoses, in which nuclear medicine examinations have been particularly helpful in terms of the final diagnosis or follow-up. The cases presented chiefly involve patients with neurodegenerative disorders, epilepsy and brain tumors. The book is intended for nuclear medicine specialists as well as clinicians, offering essential guidance on the interpretation of neurology cases in the clinical setting, particularly with regard to correctly interpreting diagnostic imaging procedures. The authors were selected from the members of the Neuroimaging Committee of the EANM and have extensive experience as clinicians and teachers within the Nuclear Medicine Community.

In the new edition of this very successful book, European and North American experts present the state of the art in diagnostic and therapeutic radionuclide procedures. The aim is to examine established and emerging clinical applications in detail, rather than to consider everything included in the comprehensive texts already available within the field. This “practical” approach ensures that the book will be a valuable guide for nuclear medicine physicians, technologists, students, and interested clinicians alike. This edition of Clinical Nuclear Medicine has been extensively revised to take account of recent developments. The roles of SPECT/CT, PET/CT, and PET/MRI are clearly explained and illustrated, and the coverage extended to encompass, for example, novel PET tracers and therapeutic radionuclides, advanced techniques of brain imaging, and the development of theranostics. Readers will be fully persuaded of the ever-increasing value of nuclear medicine techniques in depicting physiology and function and complementing anatomic modalities such as CT, MRI, and ultrasound.

The fourth edition of Clinical Nuclear Medicine highlights the continued growth in clinical applications for PET and other aspects of molecular imaging. With its problem-oriented clinical approach, the book presents relevant topics of current importance to the practicing clinician rather than providing a comprehensive review of all technical and basic science aspects. An initial section covers the broad principles and scope of important areas that are considered to have impacted more significantly on current and future clinical practice since the last edition. The second section covers all the clinical systems where nuclear medicine helps current clinical practice, while a third section covers a number of relevant technical topics.

Nuclear medicine is the bridge between a particular clinical problern and a relevant test using radionuclides. It began as a minor technical tool used in a few branches of medicine, notably endocrinology and nephrology. However, throughout the world it has now become established as a clinical discipline in its own right, with specific training programmes, special skills and a particular approach to patient management. Although the practising nuclear medicine physician must necessarily learn a great deal of basic science and technology, a sound medical training and a clinical approach to the subject remains of fundamental importance. It is for this reason that we have attempted in this book to approach the subject from a clinical standpoint, including where necessary relevant physiological material. There exist many excellent texts which cover the basic science and technology of nuclear medicine. We have, therefore, severely limited our coverage of these aspects of the subject to matters which we felt tobe essential, particularly those which have been less well covered in other texts- for example, the contents of Chapter 20 on Measurement by Royal and McNeill. Similarly, we have limited details of methodology to skeletal summaries of protocol (Appendix 1) and have included at the end of some chapters descriptions of particular techniques where we and the authors felt that it would be helpful.

The long-awaited third edition of An Atlas of Clinical Nuclear Medicine has been revised and updated to encapsulate the developments in the field since the previous edition was published nearly two decades ago.Highlights of the Third Edition:Adopts a structured format throughout for quick assimilationIncludes expanded coverage of new radiopharmaceu